Heikki Nieminen

Prof. Heikki Nieminen


Research Focus & Metrics

Academic Career Length

25Years (2002-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
8 September 2011 in European Radiology
Verified
Journal Article
Open access
PDF file
MVM. J. Voogt
M. J. Voogt
HTH. Trillaud
H. Trillaud
YKY. S. Kim
Y. S. Kim
WMW. P. Th. M. Mali
W. P. Th. M. Mali
JBJ. Barkhausen
J. Barkhausen
MBMaurice A. A. J. van Den Bosch
Maurice A. A. J. van Den Bosch
Objective The purpose of this prospective multicenter study was to assess the safety and technical feasibility of volumetric Magnetic Resonance-guided High Intensity Focused Ultrasound (MR-HIFU) ablation for treatment of patients with symptomatic uterine fibroids. Methods Thirty-three patients with 36 fibroids were treated with volumetric MR-HIFU ablation. Treatment capability and technical feasibility were assessed by comparison of the Non-Perfused Volumes (NPVs) with MR thermal dose predicted treatment volumes. Safety was determined by evaluation of complications or adverse events and unintended lesions. Secondary endpoints were pain and discomfort scores, recovery time and length of hospital stay. Results The mean NPV calculated as a percentage of the total fibroid volume was 21.7%. Correlation between the predicted treatment volumes and NPVs was found to be very strong, with a correlation coefficient r of 0.87. All patients tolerated the treatment well and were treated on an outpatient basis. No serious adverse events were reported and recovery time to normal activities was 2.3 ± 1.8 days. Conclusion This prospective multicenter study proved that volumetric MR-HIFU is safe and technically feasible for the treatment of symptomatic uterine fibroids. Key Points • Magnetic-resonance-guided high intensity focused ultrasound allows non-invasive treatment of uterine fibroids. • Volumetric feedback ablation is a novel technology that allows larger treatment volumes • MR-guided ultrasound ablation of uterine fibroids appears safe using volumetric feedback

1 April 2002 in Ultrasound in Medicine & Biology
Verified
Journal Article
Closed access
PDF file
HNHeikki Nieminen
Heikki Nieminen
JTJuha Töyräs
Juha Töyräs
JRJarno Rieppo
Jarno Rieppo
MNMiika T Nieminen
Miika T Nieminen
JHJani Hirvonen
Jani Hirvonen
JJJukka S Jurvelin
Jukka S Jurvelin

4 September 2015 in Scientific Reports
Verified
Journal Article
Open access
MSMaria Sundvik
Maria Sundvik
HNHeikki Nieminen
Heikki Nieminen
ASAri Salmi
Ari Salmi
PPPertti Panula
Pertti Panula
EHEdward Hæggström
Edward Hæggström
Acoustic levitation provides potential to characterize and manipulate material such as solid particles and fluid in a wall-less environment. While attempts to levitate small animals have been made, the biological effects of such levitation have been scarcely documented. Here, our goal was to explore if zebrafish embryos can be levitated (peak pressures at the pressure node and anti-node: 135 dB and 144 dB, respectively) with no effects on early development. We levitated the embryos (n = 94) at 2–14 hours post fertilization (hpf) for 1000 (n = 47) or 2000 seconds (n = 47). We compared the size and number of trunk neuromasts and otoliths in sonicated samples to controls (n = 94) and found no statistically significant differences (p > 0.05). While mortality rate was lower in the control group (22.3%) compared to that in the 1000 s (34.0%) and 2000 s (42.6%) levitation groups, the differences were statistically insignificant (p > 0.05). The results suggest that acoustic levitation for less than 2000 sec does not interfere with the development of zebrafish embryos, but may affect mortality rate. Acoustic levitation could potentially be used as a non-contacting wall-less platform for characterizing and manipulating vertebrae embryos without causing major adverse effects to their development.

1 September 2015 in Osteoarthritis and Cartilage
Verified
Journal Article
Open access
HNHeikki Nieminen
Heikki Nieminen
TYT. Ylitalo
T. Ylitalo
SKSakari Karhula
Sakari Karhula
JSJussi Petteri Suuronen
Jussi Petteri Suuronen
SKS. Kauppinen
S. Kauppinen
SSSimo Saarakkala
Simo Saarakkala
Collagen distribution within articular cartilage (AC) is typically evaluated from histological sections, e.g., using collagen staining and light microscopy (LM). Unfortunately, all techniques based on histological sections are time-consuming, destructive, and without extraordinary effort, limited to two dimensions. This study investigates whether phosphotungstic acid (PTA) and phosphomolybdic acid (PMA), two collagen-specific markers and X-ray absorbers, could (1) produce contrast for AC X-ray imaging or (2) be used to detect collagen distribution within AC. We labeled equine AC samples with PTA or PMA and imaged them with micro-computed tomography (micro-CT) at pre-defined time points 0, 18, 36, 54, 72, 90, 180, 270 h during staining. The micro-CT image intensity was compared with collagen distributions obtained with a reference technique, i.e., Fourier-transform infrared imaging (FTIRI). The labeling time and contrast agent producing highest association (Pearson correlation, Bland-Altman analysis) between FTIRI collagen distribution and micro-CT -determined PTA distribution was selected for human AC. Both, PTA and PMA labeling permitted visualization of AC features using micro-CT in non-calcified cartilage. After labeling the samples for 36 h in PTA, the spatial distribution of X-ray attenuation correlated highly with the collagen distribution determined by FTIRI in both equine (mean ± S.D. of the Pearson correlation coefficients, r = 0.96 ± 0.03, n = 12) and human AC (r = 0.82 ± 0.15, n = 4). PTA-induced X-ray attenuation is a potential marker for non-destructive detection of AC collagen distributions in 3D. This approach opens new possibilities in development of non-destructive 3D histopathological techniques for characterization of OA.

1 April 2004 in Ultrasound in Medicine & Biology
Verified
Journal Article
Closed access
HNHeikki Nieminen
Heikki Nieminen
SSSimo Saarakkala
Simo Saarakkala
MLMikko S. Laasanen
Mikko S. Laasanen
JHJani Hirvonen
Jani Hirvonen
JJJukka S. Jurvelin
Jukka S. Jurvelin
JTJuha Töyräs
Juha Töyräs

24 May 2019 in Archives of Pathology & Laboratory Medicine
Verified
Journal Article
Closed access
KPKenneth P. H. Pritzker
Kenneth P. H. Pritzker
HNHeikki Nieminen
Heikki Nieminen
Context.—: Needle biopsy of diseased tissue is an essential diagnostic tool that is becoming even more important as precision medicine develops. However, the capability of this modality to efficiently provide samples adequate for diagnostic and prognostic analysis remains quite limited relative to current diagnostic needs. For physicians and patients, inadequate biopsy frequently leads to diagnostic delay, procedure duplication, or insufficient information about tumor biology leading to delay in treatment; for health systems, this results in substantial incremental costs and inefficient use of scarce specialized diagnostic resources. Objective.—: To review current needle biopsy technology, devices, and practice with a perspective to identify current limitations and opportunities for improvement in the context of advancing precision medicine. Data Sources.—: PubMed searches of fine-needle aspiration and core needle biopsy devices and similar technologies were made generally, by tissue site, and by adequacy as well as by health economics of these technologies. Conclusions.—: Needle biopsy adequacy can be improved by recognizing the importance of this diagnostic tool by promoting common criteria for needle biopsy adequacy; by optimizing needle biopsy procedural technique, technologies, clinical practice, professional education, and quality assurance; and by bundling biopsy procedure costs with downstream diagnostic modalities to provide better accountability and incentives to improve the diagnostic process.